{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:04:10Z","timestamp":1793646250846,"version":"4.5.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.biopha.2021.112341","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T21:02:57Z","timestamp":1634850177000},"page":"112341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Effect of deprescribing in elderly patients with type 2 diabetes: iDegLira might improve quality of life"],"prefix":"10.1016","volume":"144","author":[{"given":"Stefano","family":"Rizza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Piciucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mavilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Tatonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Nucera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112341_bib1","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/j.1532-5415.2004.52467.x","article-title":"The relationship between number of medications and weight loss or impaired balance in older adults","volume":"52","author":"Agostini","year":"2004","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.biopha.2021.112341_bib2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.39503.424653.80","article-title":"Prescribing in older people","volume":"336","author":"Milton","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.biopha.2021.112341_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2318-9-5","article-title":"Inappropriate prescribing and adverse drugs events in older people","volume":"9","author":"Hamilton","year":"2009","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.biopha.2021.112341_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/ageing\/afm189","article-title":"Inappropriate prescribing in the older population: need for new criteria","volume":"37","author":"O\u2019Mahony","year":"2008","journal-title":"Age Ageing"},{"key":"10.1016\/j.biopha.2021.112341_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2125.2007.02961.x","article-title":"Relationship between polypharmacy and underprescribing","volume":"65","author":"Kuijpers","year":"2008","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2021.112341_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40266-014-0163-7","article-title":"Medication non-adherence among elderly patients newly discharged and receiving polypharmacy","volume":"31","author":"Pasina","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1016\/j.biopha.2021.112341_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.maturitas.2016.06.006","article-title":"Deprescribing in older people","volume":"91","author":"Page","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.biopha.2021.112341_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.biopha.2021.112341_bib9","series-title":"Medication without Harm: WHO Global Patient Safety Challenge on Medication Safety","year":"2017"},{"key":"10.1016\/j.biopha.2021.112341_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13300-016-0220-9","article-title":"Lack of evidence to guide deprescribing of antihyperglycemics: a systematic review","volume":"8","author":"Black","year":"2017","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.biopha.2021.112341_bib11","first-page":"10671","article-title":"IDegLira fixed-ratio combination in the real world: a retrospective observational single-center Italian experience","volume":"24","author":"Di Loreto","year":"2020","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.112341_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s13300-020-00945-4","article-title":"Real-world evaluation of glycemic outcomes and extra-glycemic parameters in diabetic patients treated with the combined formulation degludec-liraglutide (Ideglira)","volume":"12","author":"Zenari","year":"2021","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.biopha.2021.112341_bib13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/dom.13182","article-title":"Use and effectiveness of a fixed-ratio combination of insulin degludec\/liraglutide (IDegLira) in a real-world population with type 2 diabetes: results from a European, multicentre, retrospective chart review study","volume":"20","author":"Price","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.biopha.2021.112341_bib14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2337\/dc17-1114","article-title":"Efficacy and safety of iDegLira versus Basal-bolus insulin therapy in patients with type 2 diabetes uncontrolled on metformin and basal insulin: the DUAL VII randomized clinical trial","volume":"41","author":"Billings","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2021.112341_bib15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","article-title":"Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs","volume":"4","author":"Lakens","year":"2013","journal-title":"Front. Psychol."},{"key":"10.1016\/j.biopha.2021.112341_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/dia.2019.0372","article-title":"Canagliflozin increases calorie intake in type 2 diabetes without changing the energy ratio of the three macronutrients: CANA-K study","volume":"22","author":"Matsuba","year":"2020","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.biopha.2021.112341_bib17","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.2337\/dc16-1073","article-title":"Evaluating the experience of children with type 1 diabetes and their parents taking part in an artificial pancreas clinical trial over multiple days in a diabetes camp setting","volume":"39","author":"Troncone","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2021.112341_bib18","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/gerona\/glv028","article-title":"Unmet need for ADL assistance is associated with mortality among older adults with mild disability","volume":"70","author":"He","year":"2015","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.biopha.2021.112341_bib19","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.3390\/ijms18112493","article-title":"The role of glucagon-like peptide 1 (GLP1) in type 3 diabetes: GLP-1 controls insulin resistance, neuroinflammation and neurogenesis in the brain","volume":"18","author":"Bae","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112341_bib20","doi-asserted-by":"crossref","first-page":"17490","DOI":"10.1038\/s41598-017-17718-y","article-title":"Blood-brain glucose transfer in Alzheimer\u2019s disease: effect of GLP-1 analog treatment","volume":"7","author":"Gejl","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.112341_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuroscience.2011.02.023","article-title":"Preproglucagon neurons project widely to autonomic control areas in the mouse brain","volume":"180","author":"Llewellyn-Smith","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2021.112341_bib22","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1212\/WNL.0b013e3182661f74","article-title":"Amyloid-\u03b2 assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study","volume":"79","author":"Doraiswamy","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2021.112341_bib23","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-161256","article-title":"Effects of regular and long-acting insulin on cognition and Alzheimer\u2019s disease biomarkers: a pilot clinical trial","volume":"57","author":"Craft","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2021.112341_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/JOE-16-0478","article-title":"The effects of liraglutide in mice with diet-induced obesity studied by metabolomics","volume":"233","author":"Bug\u00e1\u0148ov\u00e1","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.biopha.2021.112341_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-981-13-8023-5_28","article-title":"Relationship among dietary taurine intake, dietary attitudes, dietary behaviors, and life stress by depression in Korean female college students","volume":"1155","author":"Park","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2021.112341_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.intimp.2018.06.019","article-title":"Trigonelline mitigates lipopolysaccharide-induced learning and memory impairment in the rat due to its anti-oxidative and anti-inflammatory effect","volume":"61","author":"Khalili","year":"2018","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2021.112341_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fnagi.2018.00271","article-title":"Changes in cerebrospinal fluid tau and \u03b2-amyloid levels in diabetic and prediabetic patients: a meta-analysis","volume":"10","author":"Lu","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.biopha.2021.112341_bib28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","article-title":"Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease","volume":"66","author":"Rotman","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2021.112341_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nut.2019.03.017","article-title":"Pathways linking obesity to neuropsychiatric disorders","volume":"66","author":"Martins","year":"2019","journal-title":"Nutrition"},{"key":"10.1016\/j.biopha.2021.112341_bib30","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1038\/ncomms8489","article-title":"Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota","volume":"6","author":"Chang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2021.112341_bib31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2021.112341_bib32","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/jcem.87.3.8462","article-title":"Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations","volume":"87","author":"Aljada","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:41:17Z","timestamp":1760100077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221011252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":32,"alternative-id":["S0753332221011252"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112341","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of deprescribing in elderly patients with type 2 diabetes: iDegLira might improve quality of life","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112341"}}